Catalyst Wire Dossier Catalyst Wire Dossier

Reh-acteoside therapy

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Reh-acteoside therapy, covering 2016-02-02 to 2016-02-02. Get the full timeline:

Most recent: Clinical Trial Update: Validity and Security of Reh-acteoside Therapy for Patients of IgA Nephropathy [Phase 2, Phase 3]

See pricing